Corporate Alliance Partnership Program

Program Goals

APAO will accept corporate partnership with organizations that share a common goal in improving the delivery and quality of care to people with cancer and related diseases.
Facilitate interaction between external stakeholders, APAO leadership, and members of APAO.
Partnership will enable APAO and its membership to engage in initiatives to decrease the burden and suffering for all people affected by cancer.

Why Choose Us

APAO was the first organization dedicated to representing PAs specializing in oncology and maintains the largest membership of PAs compared to any organization representing advanced practice providers in oncology.
The mission of APAO is to promote the utilization of PAs in the delivery of exceptional care to people with cancer and related disorders, which is achieved by providing a forum for information exchange and networking in oncology, advocating for health care policies that promote the utilization of PAs and facilitating the continuing education and professional development of PAs and other healthcare professionals in oncology.

Current Partners

Gold Level | Gilead and Kite Oncology

Gilead and Kite Oncology are creating the future of oncology. Making bold strides against cancer requires a strategy built on the power of partnerships, groundbreaking technologies and unexpected clinical combinations. We have purposefully built our pipeline with a focus on depth and breadth to address the greatest unmet needs. From antibody-drug conjugates and small molecules to cell therapy-based approaches, our research and development programs are creating possibilities for people with overlooked, underserved, and difficult-to-treat cancers. We are focused on helping to bring more life to people with cancer and changing the way cancer is treated.

Gold Level | Johnson & Johnson

Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, surgery, and vision solutions. Visit jnj.com to learn more.

FOR MORE INFORMATION ON THE CORPORATE ALLIANCE PARTNERSHIP PROGRAM, click here or email admin@apao.cc